These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24059803)

  • 1. Role of epigenetics in Rett syndrome.
    Kubota T; Miyake K; Hirasawa T
    Epigenomics; 2013; 5(5):583-92. PubMed ID: 24059803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
    Tao J; Wu H; Sun YE
    Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
    Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rett syndrome and MeCP2.
    Liyanage VR; Rastegar M
    Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of the Rett syndrome experimental model mecp2
    Cortelazzo A; Pietri T; De Felice C; Leoncini S; Guerranti R; Signorini C; Timperio AM; Zolla L; Ciccoli L; Hayek J
    J Proteomics; 2017 Feb; 154():128-133. PubMed ID: 28062374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
    Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.
    Luikenhuis S; Giacometti E; Beard CF; Jaenisch R
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6033-8. PubMed ID: 15069197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of Rett syndrome and MECP2 disorders to autism.
    Neul JL
    Dialogues Clin Neurosci; 2012 Sep; 14(3):253-62. PubMed ID: 23226951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rett syndrome: insights into genetic, molecular and circuit mechanisms.
    Ip JPK; Mellios N; Sur M
    Nat Rev Neurosci; 2018 Jun; 19(6):368-382. PubMed ID: 29740174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK; Bailey ME; Cobb SR
    Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress of Rett syndrome causing gene MECP2--the structure, function and modulation of MECP2].
    Zhang JJ; Bao XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 41(6):712-5. PubMed ID: 20019788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
    Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
    Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR.
    Ebert DH; Gabel HW; Robinson ND; Kastan NR; Hu LS; Cohen S; Navarro AJ; Lyst MJ; Ekiert R; Bird AP; Greenberg ME
    Nature; 2013 Jul; 499(7458):341-5. PubMed ID: 23770587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research.
    Zachariah RM; Rastegar M
    Neural Plast; 2012; 2012():415825. PubMed ID: 22474603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
    Braunschweig D; Simcox T; Samaco RC; LaSalle JM
    Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
    Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
    Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The story of Rett syndrome: from clinic to neurobiology.
    Chahrour M; Zoghbi HY
    Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
    Martínez de Paz A; Ausió J
    Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.